According to a report, the American multinational technology company Apple’s smartwatch will be integrating features to enable it to monitor the wearers’ blood pressure, apart from glucose and alcohol levels.
The iPhone maker has reportedly entered into a deal with a British electronics startup, Rockley Photonics that designs sensors for monitoring blood using infrared light.
The timeline for the launch of the speculated new Apple Watch model is not known yet.
Recently, it was reported that Apple is working on a new rugged variant for use in extreme environments. People familiar with the development had suggested that this second model will be aimed at athletes and sports enthusiasts.
As per a report, the chip manufacturing startup in its US Securities and Exchange Commission (SEC) filing revealed that Apple is one of its few large customers. And it is possible that the glucose and alcohol level monitoring may be launched in the future Apple Watch model. The startup reportedly stated the two largest customers accounted for 100 percent of the firm’s revenue in 2020, and 99.6 percent in 2019.
Rockley Photonics develops sensors for monitoring health and wellness, which are said to include applications such as blood measurements using infrared light and they are claimed to be capable of monitoring blood pressure, as well as glucose and alcohol levels.
The link between the startup, and Apple signals that the iPhone maker may bring up blood sugar monitoring features in its future products. The report also cited Rockley Photonics CEO Andrew Rickman who says that the technology developed by the company will be in consumer products by 2022.
Apple Watch currently includes a sensor for measuring heart rate and it is also said that the new rugged variant called the Explorer Edition, which could be added to the existing models later this year or by 2022.
Related: Spotify takes on Apple: Unveils platform for paid podcast subscription